Investor Type | Firm |
Type of Fund | Venture Capital Fund |
Industries | BioTech • CleanTech • Material Science • Life Science • Mobile |
Stages | Startup, Early Stage,Seed,Later |
Investing | United States • Switzerland • Europe |
Syno Capital is a New York-based venture capital firm with an additional office in Hong Kong. Founded in 2015, the firm operates at the intersection of healthcare and information technology sectors. They have an investment thesis that concentrates on seed, early stage, and later stage investments, aiming to foster progress through innovations. The firm is committed to solving healthcare challenges by funding and working with the greatest minds across the globe. Their investment philosophy is rooted in three key principles: innovation, rigor, and discipline. They believe that significant progress in healthcare can only be achieved by embracing innovation as a means to address the most daunting problems. They are guided by science and data, emphasizing thorough research and avoiding shortcuts. Moreover, they follow a disciplined investment approach, seeking to deliver strong returns for investors based on a consistent risk-reward framework. With expertise in equity, Syno Capital specializes in startups and takes a hands-on approach to help them grow. They focus on the areas of BioTech, CleanTech, Material Science, Life Science, and Mobile technologies. The firm aims to build the next generation of healthcare companies by backing breakthrough innovations that can lead to significant advancements in the industry. Syno Capital promotes collaboration with talented entrepreneurs and is on the lookout for opportunities to transform ideas into tangible solutions that can meet the healthcare challenges of today and tomorrow.